Drugs / MT218
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06262139 | Jul 2024 → Dec 2026 expected | — | Songqi Gao | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MT218 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06262139 ↗ |
| Route | Intravenous | “Each patient will receive a single intravenous injection of MT218” NCT06262139 ↗ |